Result
€62,337 ▲ 38×
The result rose in 2025 from €1,631 to €62,337.
KINDADERM
Lifetime
2 annual accounts with figures on one time axispeak €83,455 (2025)
€83,455▲ 33×
peak €62,337 (2025)
€62,337▲ 38×
peak €66,968 (2025)
€66,968▲ 14×
€11,655▼ 27.6%
Board1 name since 2024
1 director
Documentsfilings and deeds
01-06-202660 days before the deadline
2025micro format
Gross margin from €2,496 to €83,455Result from €1,631 to €62,337Registered office moved from Anderlecht to Waterloo 30-09Equity from €4,631 to €66,968Debts from €16,103 to €11,655Investments €15,587
Key points
from the 2025 annual accountsInvestments
€16,848 4.5 × depreciation
Green is investment, beige is depreciation.
Liquidity
4.97 was 1.00 in 2024
Short-term debts fell from €11,851 to €11,655.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as KINDADERM has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for KINDADERM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1014777475
Registered office moved from Anderlecht to Waterloo
New registered office: Avenue du Longchamp 4, 1410 Waterloo · Previous registered office: Avenue des Hortensias 24/10, 1070 Anderlecht · Registered office clause: Avenue des Hortensias 24/10, 1070 Anderlecht · General meeting of 21-08-2025 · Gazette deed
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 10-10-2024 · Gazette deed
First establishment
Avenue du Longchamp 4, Waterloo
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| KINDADERM Waterloo | €78,623 | €83,455 | 85.2% | - |
| Docteur Catherine Braeken Ottignies-Louvain-la-Neuve | €79,957 | €79,607 | 69.5% | - |
| VB MEDICAL Villers-la-Ville | €81,846 | €85,921 | 81.5% | - |
| Mainclaire Braine-l'Alleud | €90,089 | €81,590 | 85.4% | - |
| Dr. Vermeulen Radiologie Ghent | €83,056 | €82,708 | 74.5% | - |
| Gertjan Vanderhaegen Psychiater Antwerp | €83,867 | €85,730 | 78.9% | - |
| Dr. Pyl Dermatologie Kalmthout | €81,283 | €77,268 | 74.6% | - |
These companies have the same main activity as KINDADERM: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €80,000 and €90,100, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 08-10-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.364.772.8961410 Waterloo, since 08-10-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 24-01-2026
Annual accounts 2025
- ≈ €190,000estimated
- €78,623▲ 279%
- Filing
- Filed on 01-06-2026, 60 days before the end of the filing period
Insights on KINDADERM
KINDADERM has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €66,968 and a net result of €62,337.
Its solvency ranks better than 77% of 21,330 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KINDADERM
- What is the company number of KINDADERM?
- The company number of KINDADERM is 1014.777.475. The VAT number is the same number with BE in front: BE 1014.777.475.
- Where is KINDADERM based?
- The registered office is at Avenue du Longchamp 4, 1410 Waterloo.Company details
- What does KINDADERM do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of KINDADERM?
- KINDADERM is a private limited company (BV).
- When was KINDADERM founded?
- KINDADERM was founded on 08-10-2024.
- Is KINDADERM still active?
- Yes, KINDADERM is an active enterprise in the KBO register.
- What is the turnover of KINDADERM?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €83,455 and 34 comparable companies (NACE 862). It probably lies between €140,000 and €230,000.Financials
- Is KINDADERM profitable?
- In financial year 2025, KINDADERM made a profit of €62,337.
- Where can I find the annual accounts of KINDADERM?
- KINDADERM filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KINDADERM due?
- KINDADERM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.